P Palthera

Common questions

GHRP-6 — questions, answered plainly.

6 research-context questions about GHRP-6. Answers stay neutral and reference what is published in the peer-reviewed literature — no dosing, no human-use guidance, no extrapolation beyond what the cited studies report.

  1. 01

    What is GHRP-6?

    GHRP-6 is a first-generation synthetic growth hormone-releasing hexapeptide developed by Bowers and colleagues in the 1980s. It established the GHRP class and remains a reference compound in receptor pharmacology research.

  2. 02

    How is GHRP-6 different from other GHRPs?

    GHRP-6 is the historical reference. Subsequent GHRPs (GHRP-2, hexarelin, ipamorelin) were developed to refine potency, selectivity, or pharmacokinetics relative to GHRP-6. The Ghigo 1997 review (PMID 9186261) covers the family relationships.

  3. 03

    What does the Cibrián 2006 organ-failure study show?

    Cibrián et al. 2006 (Clinical Science, PMID 16417467) reported that GHRP-6 enhanced epithelial cell migration in vitro and was associated with reduced hepatic, intestinal, lung, and renal injury in a rat ischaemia / reperfusion organ-failure model.

  4. 04

    What does the recent doxorubicin cardiotoxicity study show?

    Berlanga-Acosta et al. 2024 (Frontiers in Pharmacology, PMID 38873418) reported that GHRP-6 co-administration with doxorubicin in rats was associated with preserved cardiac function, reduced extra-myocardial organ damage, and activation of cellular survival pathways.

  5. 05

    Is GHRP-6 approved as a medicine?

    No. GHRP-6 is not approved by the FDA, MHRA, or EMA at the time of writing. The compound is referenced here in research contexts only.

  6. 06

    What are the limits of the GHRP-6 evidence?

    Cytoprotection and organ-failure data are predominantly from rodent models; extrapolation to clinical outcomes is not established. Most human evidence is from early-phase pharmacology studies in GH secretion.

Important

These answers are not medical advice.

GHRP-6 is referenced in research literature only. Palthera does not provide dosage, cycling, stacking, or injection guidance, and content is not intended to support consumer or therapeutic use. Speak to a qualified clinician for any health decisions.